| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61703-342-22 | 61703-342 | HUMAN PRESCRIPTION DRUG | Paclitaxel | PACLITAXEL | INJECTION, SOLUTION | INTRAVENOUS | 20040301 | N/A | ANDA | ANDA076131 | Hospira, Inc. | PACLITAXEL | 6 mg/mL | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-22) / 16.7 mL in 1 VIAL, MULTI-DOSE |
| 61703-342-50 | 61703-342 | HUMAN PRESCRIPTION DRUG | Paclitaxel | PACLITAXEL | INJECTION, SOLUTION | INTRAVENOUS | 20040301 | N/A | ANDA | ANDA076131 | Hospira, Inc. | PACLITAXEL | 6 mg/mL | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-50) / 50 mL in 1 VIAL, MULTI-DOSE |
| 61703-342-09 | 61703-342 | HUMAN PRESCRIPTION DRUG | Paclitaxel | PACLITAXEL | INJECTION, SOLUTION | INTRAVENOUS | 20040301 | N/A | ANDA | ANDA076131 | Hospira, Inc. | PACLITAXEL | 6 mg/mL | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-09) / 5 mL in 1 VIAL, MULTI-DOSE |